Tenet Healthcare (THC) Tops Q2 EPS by 114c; offers guidance

Tenet Healthcare (NYSE: THC) reported Q2 EPS of $4.02, $1.14 better than the analyst estimate of $2.88. Revenue for the quarter came in at $5.27 billion versus the consensus estimate of $5.16 billion.

GUIDANCE:

Tenet Healthcare sees FY2025 EPS of $15.55-$16.21, versus the consensus of $12.83. Tenet Healthcare sees FY2025 revenue of $20.95-21.25 million, versus the consensus of $20.92 million.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Popular stocks with increasing option volume: MU SPCX INTC AMD SNDK IREN PLTR AVGO SOFI NKE MSTR NBIS ORCL
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance